Questions: Bacterial Cell Organization and Ultrastructure

Question 1

A researcher is studying why certain beta-lactam antibiotics are less effective against gram-negative bacteria than gram-positive bacteria. Which ultrastructural feature of gram-negative cells best explains this difference?

• A. Gram-negative bacteria have larger 80S ribosomes that are not targeted by beta-lactams
• B. Gram-negative bacteria have an outer membrane that restricts drug access to the peptidoglycan, and their periplasmic space can harbor beta-lactamase enzymes
• C. Gram-positive bacteria have thinner peptidoglycan that is more sensitive to disruption by beta-lactams
• D. Gram-negative bacteria lack peptidoglycan entirely, so beta-lactams have no target

Answer: (B)

Gram-negative bacteria have a double-membrane architecture: an inner (plasma) membrane, a thin peptidoglycan layer, and an outer membrane containing LPS. The outer membrane is a physical barrier that restricts entry of many hydrophilic antibiotics. More importantly, the periplasmic space between the two membranes can harbor beta-lactamases — enzymes that destroy the antibiotic before it reaches the peptidoglycan. Gram-positive bacteria have thick exposed peptidoglycan with no outer membrane, making it directly accessible. Option D is wrong: gram-negative bacteria do have peptidoglycan, just a thinner layer.

Question 2

Bacterial 70S ribosomes are structurally distinct from the 80S ribosomes of eukaryotic cells. What is the direct clinical significance of this difference?

• A. It means bacteria synthesize proteins faster than human cells, contributing to rapid growth
• B. It explains how bacteria can translate proteins without a nucleus — the smaller ribosome fits in the cytoplasm
• C. It is the structural basis for selective antibiotic targeting — drugs designed to bind 70S ribosomes inhibit bacterial protein synthesis without affecting human cells
• D. It means bacteria must use a slightly different genetic code, requiring different tRNA molecules

Answer: (C)

The size difference between 70S (bacterial) and 80S (eukaryotic) ribosomes reflects structural differences in ribosomal RNA and proteins. This is the foundation of antibiotic selectivity for an entire class of drugs: aminoglycosides, tetracyclines, macrolides, chloramphenicol, and linezolid all target bacterial ribosome subunits. They can kill bacteria without harming the human host's cells because their binding sites do not exist on 80S ribosomes. This is one of the most medically important structural differences between prokaryotes and eukaryotes.

Question 3

In bacteria, transcription and translation occur simultaneously in the cytoplasm — ribosomes begin translating mRNA while it is still being synthesized.

• T. True
• F. False

Answer: True

True — because bacteria lack a nuclear membrane, there is no spatial separation between the chromosome and the cytoplasm. Ribosomes attach to mRNA and begin translation while RNA polymerase is still transcribing. This co-transcriptional translation is impossible in eukaryotes, where mRNA must be processed and exported from the nucleus before ribosomes can access it. The coupling of transcription and translation in bacteria has important consequences for gene regulation (attenuation) and explains why bacterial cells can respond almost immediately to environmental changes.

Question 4

The bacterial cell wall is a rigid, static structure whose mainly role is to resist osmotic lysis.

• T. True
• F. False

Answer: False

The cell wall is dynamic and continuously remodeled — particularly during cell division, when the wall must be cleaved and rebuilt to allow daughter cell separation, and during growth, when new peptidoglycan subunits are inserted. It is not merely a passive container: it serves as a scaffold for surface proteins, provides structural integrity in varying osmotic conditions, and is susceptible to targeted enzymatic degradation (e.g., lysozyme cleaves peptidoglycan bonds). Describing it as 'rigid and static' misses the biology of how bacteria actually grow and divide.

Question 5

Why do gram-negative bacteria pose greater challenges for antibiotic therapy than gram-positive bacteria? Describe two specific ultrastructural features that contribute to this.

Model answer: Two key features: (1) The outer membrane — gram-negatives have an additional lipid bilayer outside the thin peptidoglycan layer, containing LPS. This outer membrane physically restricts the entry of many antibiotics, especially hydrophilic drugs and large molecules. (2) The periplasmic space — the region between the outer and inner membranes can accumulate degradative enzymes like beta-lactamases, which destroy antibiotics before they reach their target in the peptidoglycan or membrane. Gram-positive bacteria lack the outer membrane entirely, so their thick peptidoglycan is directly exposed and accessible.

These two features together constitute a two-barrier defense: the outer membrane limits access, and the periplasm provides an enzymatic destruction zone. This is why gram-negative infections like those caused by Pseudomonas or Klebsiella are notoriously difficult to treat and why multidrug resistance is especially concerning in gram-negative pathogens.